| 4/21/2021 |
QLIFE signs exclusive European distribution agreement with Aidian |
cision.com |
QLIFE signs exclusive European distribution agreement with Aidian Wed, Apr 21, 2021 13:07 CETQlife has signed an exclusive European distribution agreement with Aidian Oy, for the Egoo.Health device and Sars-CoV2-capsule for the clinical diagnostics market . Aidian Oy is a market leading In Vitro Diagnostics (IVD) company based in Finland.The agreement covers a range of European countries, including Sweden, Norway, Finland, Germany, Netherlands, Belgium, Luxembourg, Austria, Switzerland ... |
| 3/31/2021 |
Clinical diagnostics Market Trends, Size, Share | Global Industry Outlook and Statistics, Segmentation and Forecast to 2027 |
Wordpress.com |
United States, New York City)The Clinical diagnostics market intelligence study is a collection of authentic information and extensive analyses of the data by taking into consideration the market trends, growth prospects, emerging sectors, challenges, and drivers, which can help investors and stakeholders identify the most beneficial approaches suited for the contemporary and potential market landscape. It provides critical information pertaining to both the current and projected growth of the ... |
| 3/5/2021 |
Clinical Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) |
Yahoo News |
The clinical diagnostics market is projected to register a CAGR of 6. 1% during the forecast period, with a revenue of approximately USD 63,305 million in 2020 and expected to reach USD 93,851 million by 2026.New York, March 05, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Clinical Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" - https://www.reportlinker.com/p06030479/?utm_source=GNWThe market ... |
| 3/4/2021 |
Global Clinical Diagnostics Market (2021-2026) with Top Growth Companies: Abaxis, Abbott Diagnostics, Beckman Coulter, Becton Dickinson and Company, BioMerieux SA |
ksusentinel.com |
Publish PRs Search for Home / Science / Global Clinical Diagnostics Market (2021-2026) with Top Growth Companies: Abaxis, Abbott Diagnostics, Beckman Coulter, Becton Dickinson and Company, BioMerieux SA Global Clinical Diagnostics Market (2021-2026) with Top Growth Companies: Abaxis, Abbott Diagnostics, Beckman Coulter, Becton Dickinson and Company, BioMerieux SA apexresearch March 4, 2021The Years Considered for The Study in The Clinical Diagnostics Market Report Are as Follows: Historical year: 2018 (Pre-COVID ... |
| 1/25/2021 |
Global Clinical Diagnostics Market Forecast 2026 |
Wordpress.com |
Bharat Book Bureau Provides the Trending Market Research Report on “Global Clinical Diagnostics Market By Type of Test (Lipid Panel, Metabolic Panel, Complete Blood Count, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Assays and Kits, Software & Services), By Application (Infectious Disease, Cardiovascular, Cancer, Others), By End-User (Diagnostic Laboratory, Hospital & Clinics, Others) By Region, Competition, Forecast & Opportunities, 2026 ” under Diagnostics Category. The report offers a collection of superior ... |
| 1/25/2021 |
Global Clinical Diagnostics Market By Type of Test, By Product, By Application, By End-User By Region, Competition, Forecast & Opportunities, 2026 |
Globe Newswire |
New York, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Clinical Diagnostics Market By Type of Test, By Product, By Application, By End-User By Region, Competition, Forecast & Opportunities, 2026" - https://www.reportlinker.com/p05885388/?utm_source=GNWThe global clinical diagnostics market was valued at around USD 56 billion in 2020 and is expected to grow at a steady CAGR of 8.59% during the forecast period ... |
| 1/24/2021 |
Critical Survey: Luminex (NASDAQ:LMNX) versus Alphatec (NASDAQ:ATEC) |
American Banking News |
... nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market ; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite ... |
| 1/24/2021 |
Critical Survey: Luminex (NASDAQ:LMNX) versus Alphatec (NASDAQ:ATEC) |
rivertonroll.com |
... nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market ; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite ... |
| 1/22/2021 |
Infectious Disease to Dominate Clinical Diagnostics Market During Forecast Period – TechSci Research |
Wordpress.com |
Infectious Disease to Dominate Clinical Diagnostics Market During Forecast Period – TechSci ResearchIncreasing adoption of point of care testing and rising prevalence of COVID-19 is expected to drive growth of global clinical diagnostics marketAccording to TechSci Research report, “ Global Clinical Diagnostics Market By Type of Test (Lipid Panel, Metabolic Panel, Complete Blood Count, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Assays and Kits, Software & Services ... |
| 1/22/2021 |
Infectious Disease to Dominate Clinical Diagnostics Market During Forecast Period |
techsciblog.com |
Home Healthcare Infectious Disease to Dominate Clinical Diagnostics Market During Forecast Period Infectious Disease to Dominate Clinical Diagnostics Market During Forecast Period By TechSci Research Healthcare 0 CommentsIncreasing adoption of point of care testing and rising prevalence of COVID-19 is expected to drive growth of global clinical diagnostics marketAccording to TechSci Research report, “ Global Clinical Diagnostics Market By Type of Test (Lipid Panel, Metabolic Panel, Complete ... |
| 12/16/2020 |
Attana completes FDA Medical Device Class 1 listing and facility registration |
cision.com |
... and Drug Administration (FDA).The facility registration and listing of Attana Cell™ 250 as a Class I device (510(k) exempt) are the first regulatory requirements for marketing Attana’s instruments towards the clinical diagnostics market . In 2021, Attana intends to complement these by filing for an FDA approval of at least one complementary assay as a Class II device, subject to 510(k) clearance. Simultaneous to these efforts ... |
| 9/7/2020 |
2020-2029 Report on Global Clinical Mass Spectrometry Market by Player, Region, Type, Application and Sales Channel |
reportsnreports.com |
... perspectives in the Clinical Mass Spectrometry market. Leading players of Clinical Mass Spectrometry including: - Thermo Fisher Market split by Type, can be divided into: - LC-MS Market split by Application, can be divided into: - Clinical Diagnostics Market split by Sales Channel, can be divided into: - Direct Channel Market segment by Region/Country including: - North America (United States, Canada and Mexico) - Europe (Germany, UK, France, Italy, Russia and Spain etc.) - Asia ... |
| 9/2/2020 |
Global Generic Hematology Analyzers and Reagents Market Size, Status and Forecast 2020-2026 |
reportsmonitor.com |
... the period 2015-2026. The key players covered in this study Abbott Laboratories Danaher Corporation Siemens Bio-Rad Laboratories Roche Sysmex Corporation Nihon Kohden Boule Diagnostics HORIBA BioSystems Diatron Drew Scientific EKF Diagnostics Mindray Ortho Clinical Diagnostics Market segment by Type, the product can be split into Generic Hematology Analyzers Generic Hematology Reagents Market segment by Application, split into Hospital Clinic Laboratory Other Market segment by Regions/Countries, this report covers ... |
| 8/27/2020 |
SQI Diagnostics Inc. Announces Stock Option Grant |
PR Newswire |
... Shares). About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human ... |
| 8/27/2020 |
SQI Diagnostics Reports Third Quarter 2020 Results |
PR Newswire |
... protected] About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical-grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are "multiplexed"; which means many individual tests can now be simplified, consolidated and automated into a single test. This significantly increases sample throughput, reduces time ... |
| 8/18/2020 |
SQI Diagnostics Appoints Rob Chioini as Chief Executive Officer, Grants Options and Amends Stock Option Plan |
PR Newswire |
... meeting. About SQI Diagnostics SQI Diagnostics is a life sciences and diagnostics company that develops clinical grade multiplexed microarray and molecular assays run on its automated instrumentation for the pharmaceutical research, animal health, and clinical diagnostics market s. SQI develops custom research and diagnostic assays that are multiplexed; meaning the simplification, consolidation and automation of many individual tests into one. This increases sample throughput, reduces time, cost and chance for human ... |
| 8/15/2020 |
$PBIO Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device |
traderpower.com |
... markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important ... |
| 8/14/2020 |
Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device |
Wordpress.com |
... markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important ... |
| 8/14/2020 |
Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Consumable Device - QualityStocks |
qualitystocks.com |
... markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important ... |
| 8/14/2020 |
Pressure BioSciences, Inc. (PBIO) Receives Pivotal U.S. Patent for Novel, High-Pressure Enhanced Con |
livejournal.com |
... markets Their products are based on three key technology platforms, led by their proprietary Pressure Cycling Technology (“PCT”) The award of the PCT MicroPestle (“MP”) patent moves Pressure BioSciences even closer to entering the clinical diagnostics market , which is exponentially larger than the research products market where the Company currently transacts business The Company utilizes a “razor: razor blade” business model, and the PCT MP is the Company’s most important ... |